225 related articles for article (PubMed ID: 37679849)
1. "Dual sensitive supramolecular curcumin nanoparticles" in "advanced yeast particles" mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment.
Han X; Luo R; Qi S; Wang Y; Dai L; Nie W; Lin M; He H; Ye N; Fu C; You Y; Fu S; Gao F
J Nanobiotechnology; 2023 Sep; 21(1):321. PubMed ID: 37679849
[TBL] [Abstract][Full Text] [Related]
2. pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis.
Xu H; Luo R; Dong L; Pu X; Chen Q; Ye N; Qi S; Han X; Nie W; Fu C; Hu Y; Zhang J; Gao F
Nanomedicine; 2022 Jan; 39():102461. PubMed ID: 34562656
[TBL] [Abstract][Full Text] [Related]
3. Entrapment of Macrophage-Target Nanoparticles by Yeast Microparticles for Rhein Delivery in Ulcerative Colitis Treatment.
Chen Q; Luo R; Han X; Zhang J; He Y; Qi S; Pu X; Nie W; Dong L; Xu H; Liu F; Lin M; Zhong H; Fu C; Gao F
Biomacromolecules; 2021 Jun; 22(6):2754-2767. PubMed ID: 34019390
[TBL] [Abstract][Full Text] [Related]
4. Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment.
Ye N; Zhao P; Ayue S; Qi S; Ye Y; He H; Dai L; Luo R; Chang D; Gao F
Int J Biol Macromol; 2023 Mar; 232():123229. PubMed ID: 36642354
[TBL] [Abstract][Full Text] [Related]
5. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.
Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B
Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962
[TBL] [Abstract][Full Text] [Related]
6. β-1,3-d-Glucan based yeast cell wall system loaded emodin with dual-targeting layers for ulcerative colitis treatment.
Pu X; Ye N; Lin M; Chen Q; Dong L; Xu H; Luo R; Han X; Qi S; Nie W; He H; Wang Y; Dai L; Lin D; Gao F
Carbohydr Polym; 2021 Dec; 273():118612. PubMed ID: 34561010
[TBL] [Abstract][Full Text] [Related]
7. Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy.
Xu C; Chen S; Chen C; Ming Y; Du J; Mu J; Luo F; Huang D; Wang N; Lin Z; Weng Z
Int J Pharm; 2022 Jul; 623():121884. PubMed ID: 35661797
[TBL] [Abstract][Full Text] [Related]
8. β-1,3-d-glucan particles-based "nest" protected co-loaded Rhein and Emodin regulates microbiota and intestinal immunity for ulcerative colitis treatment.
Wang Y; Zhong S; Yang K; Luo R; Dai L; Zhong W; Ye Y; Fu C; Lin D; Li N; Chen J; Zheng C; Fu S; Gao F
Int J Biol Macromol; 2024 Mar; 260(Pt 2):128818. PubMed ID: 38103669
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of ulcerative colitis
Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Macrophages with Inflammatory Reaction in Ulcerative Colitis and Influence of Curcumin on Macrophage Chemotaxis.
Chen Y; Chen D; Zhou C; Cao X; He J
Altern Ther Health Med; 2023 Mar; 29(2):97-103. PubMed ID: 36302234
[TBL] [Abstract][Full Text] [Related]
11. Oral delivery of pectin-chitosan hydrogels entrapping macrophage-targeted curcumin-loaded liposomes for the treatment of ulcerative colitis.
Wu M; Ping H; Wang K; Ding H; Zhang M; Yang Z; Du Q
Int J Pharm; 2023 Nov; 647():123510. PubMed ID: 37839497
[TBL] [Abstract][Full Text] [Related]
12. Curcumin alleviated dextran sulfate sodium-induced colitis by recovering memory Th/Tfh subset balance.
Zheng LX; Guo KE; Huang JQ; Liu MH; Deng BL; Liu DY; Zhou BG; Zhou W; Zhong YB; Zhao HM
World J Gastroenterol; 2023 Sep; 29(36):5226-5239. PubMed ID: 37901446
[TBL] [Abstract][Full Text] [Related]
13. Oral delivery of porous starch-loaded bilayer microgels for controlled drug delivery and treatment of ulcerative colitis.
Wen Z; Kang L; Fu H; Zhu S; Ye X; Yang X; Zhang S; Hu J; Li X; Chen L; Hu Y; Yang X
Carbohydr Polym; 2023 Aug; 314():120887. PubMed ID: 37173037
[TBL] [Abstract][Full Text] [Related]
14. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.
Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C
J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012
[TBL] [Abstract][Full Text] [Related]
15. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice.
Li S; Jin M; Wu Y; Jung S; Li D; He N; Lee MS
Drug Deliv; 2021 Dec; 28(1):1120-1131. PubMed ID: 34121560
[TBL] [Abstract][Full Text] [Related]
16. pH/ROS Dual-Sensitive Natural Polysaccharide Nanoparticles Enhance "One Stone Four Birds" Effect of Rhein on Ulcerative Colitis.
Qi S; Luo R; Han X; Nie W; Ye N; Fu C; Gao F
ACS Appl Mater Interfaces; 2022 Nov; 14(45):50692-50709. PubMed ID: 36326017
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy.
Chen Q; Gou S; Ma P; Song H; Zhou X; Huang Y; Kwon Han M; Wan Y; Kang Y; Xiao B
Int J Pharm; 2019 Feb; 557():135-144. PubMed ID: 30594685
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone-Loaded Lipid Calcium Phosphate Nanoparticles Treat Experimental Colitis by Regulating Macrophage Polarization in Inflammatory Sites.
Dong K; Zhang Y; Ji HR; Guan ZL; Wang DY; Guo ZY; Deng SJ; He BY; Xing JF; You CY
Int J Nanomedicine; 2024; 19():993-1016. PubMed ID: 38299194
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages.
Hlaing SP; Cao J; Lee J; Kim J; Saparbayeva A; Kwak D; Kim H; Hwang S; Yun H; Moon HR; Jung Y; Yoo JW
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297553
[TBL] [Abstract][Full Text] [Related]
20. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
